{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1152","meta":{"versionId":"7","lastUpdated":"2021-11-02T01:01:44.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1152","version":"20211102","name":"Substance Use Disorder Short Acting Medication Administration","status":"active","date":"2021-11-02T01:01:44-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"G2067","display":"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2068","display":"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"},{"code":"G2078","display":"Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"code":"G2079","display":"Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"},{"code":"H0020","display":"Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"},{"code":"H0033","display":"Oral medication administration, direct observation"}]}]}}